CLINICAL_TRIALS
trial_result
· 2018-11-21
Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) [Phase 2]
Summary
Phase 2 trial of baricitinib in systemic lupus erythematosus completed; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2018-11-21